APA (7th ed.) Citation

Xixi Lin, Yongliang Jia, Yongliang Jia, Xinwei Dong, Xinwei Dong, Jian Shen, . . . Yicheng Xie. (2022). Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Xixi Lin, et al. Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Xixi Lin, et al. Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance. Frontiers Media S.A., 2022.